Terms: = Kidney tumors AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
243 results:
1. Interaction between anemia and hyperuricemia in the risk of all-cause mortality in patients with chronic kidney disease.
Lu Z; Lu F; Zhang R; Guo S
Front Endocrinol (Lausanne); 2024; 15():1286206. PubMed ID: 38586465
[TBL] [Abstract] [Full Text] [Related]
2. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
de Angelis M; Morra S; Scheipner L; Siech C; Jannello LMI; Baudo A; Goyal JA; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2024 Mar; 42(1):193. PubMed ID: 38530480
[TBL] [Abstract] [Full Text] [Related]
3. Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
Catalano M; Rebuzzi SE; Maruzzo M; De Giorgi U; Buti S; Galli L; Fornarini G; Zucali PA; Procopio G; Chiellino S; Milella M; Catalano F; Pipitone S; Ricotta R; Sorarù M; Mollica V; Tudini M; Fratino L; Prati V; Caffo O; Atzori F; Morelli F; Prati G; Nolè F; Vignani F; Cavo A; Di Napoli M; Malgeri A; Naglieri E; Signori A; Banna GL; Rescigno P; Antonuzzo L; Roviello G
JAMA Netw Open; 2023 Nov; 6(11):e2345185. PubMed ID: 38010650
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis.
Cui P; Li J; Tao H; Li X; Wu L; Ma J; Wang H; Liu T; Zhang M; Hu Y
Oncogene; 2023 Oct; 42(42):3098-3112. PubMed ID: 37653115
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Two Cystatin C Reagents and Four Equations on Glomerular Filtration Rate Estimations After Standardization.
Lee HS; Bae GE; Lee JE; Park HD
Ann Lab Med; 2023 Nov; 43(6):565-573. PubMed ID: 37387489
[TBL] [Abstract] [Full Text] [Related]
6. Metabolic reprogramming of clear cell renal cell carcinoma.
Zhu H; Wang X; Lu S; Ou K
Front Endocrinol (Lausanne); 2023; 14():1195500. PubMed ID: 37347113
[TBL] [Abstract] [Full Text] [Related]
7. Propofol Regulates HIF-1 α Effect of Expression of Targeted SIRT1 Signal pathway on kidney Renal Clear Cell Carcinoma.
Chen X; Li C; Zeng R; Qiu L; Huang J; Wang N; Ren X; Ling X
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):145-149. PubMed ID: 37300675
[TBL] [Abstract] [Full Text] [Related]
8. Utilization of a Virtual Tumor Board for the Care of Patients With Renal Masses: Experience From a Quality Improvement Collaborative.
Hijazi MA; Prebay ZJ; Johnson A; Wilder S; Patel A; Mehra R; Montie JE; Noyes SL; Mirza M; Jafri M; Weizer A; Sarle R; Ghani KR; Rogers C; Lane BR
Urol Pract; 2023 Jul; 10(4):380-388. PubMed ID: 37103551
[TBL] [Abstract] [Full Text] [Related]
9. Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Choueiri TK; Eto M; Motzer R; De Giorgi U; Buchler T; Basappa NS; Méndez-Vidal MJ; Tjulandin S; Hoon Park S; Melichar B; Hutson T; Alemany C; McGregor B; Powles T; Grünwald V; Alekseev B; Rha SY; Kopyltsov E; Kapoor A; Alonso Gordoa T; Goh JC; Staehler M; Merchan JR; Xie R; Perini RF; Mody K; McKenzie J; Porta CG
Lancet Oncol; 2023 Mar; 24(3):228-238. PubMed ID: 36858721
[TBL] [Abstract] [Full Text] [Related]
10. Association between
Zhang Z; Gao X; Deng L; Jia W; Zhang J; Cheng J; Zhou H; Liu G; Fu W
Biomark Med; 2022 Oct; 16(15):1113-1120. PubMed ID: 36606447
[No Abstract] [Full Text] [Related]
11. Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort Study.
van Dorst DCH; Kabadayi S; Oomen-de Hoop E; Danser AHJ; Mathijssen RHJ; Versmissen J
J Am Heart Assoc; 2023 Jan; 12(1):e028050. PubMed ID: 36583425
[TBL] [Abstract] [Full Text] [Related]
12. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.
Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
[TBL] [Abstract] [Full Text] [Related]
13. Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy.
Kooijmans ECM; van der Pal HJH; Pilon MCF; Pluijm SMF; van der Heiden-van der Loo M; Kremer LCM; Bresters D; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Neggers SJC; van Santen HM; Tissing WJE; de Vries ACH; Kaspers GJL; Veening MA; Bökenkamp A;
Scand J Clin Lab Invest; 2022; 82(7-8):541-548. PubMed ID: 36200802
[TBL] [Abstract] [Full Text] [Related]
14. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract] [Full Text] [Related]
15. Applicability of 14 Formulas for Estimating Glomerular Filtration Rate in the Evaluation of Renal Function before and after Nephron-Sparing Surgery in Patients with Renal tumors.
Li Q; Yang Z; Zheng S; Wu Y; Cai W; Hu M; Zhu Q; Ye L
Contrast Media Mol Imaging; 2022; 2022():3330442. PubMed ID: 35615732
[TBL] [Abstract] [Full Text] [Related]
16. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
[TBL] [Abstract] [Full Text] [Related]
17. Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Motzer R; Porta C; Alekseev B; Rha SY; Choueiri TK; Mendez-Vidal MJ; Hong SH; Kapoor A; Goh JC; Eto M; Bennett L; Wang J; Pan JJ; Saretsky TL; Perini RF; He CS; Mody K; Cella D
Lancet Oncol; 2022 Jun; 23(6):768-780. PubMed ID: 35489363
[TBL] [Abstract] [Full Text] [Related]
18. Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II Study (DGA Study).
Yamamoto K; Nishiyama S; Kunisada M; Iida M; Ito T; Ioroi T; Makimoto H; Omura T; Harada K; Fujisawa M; Nishigori C; Yano I
Oncologist; 2022 May; 27(5):e384-e392. PubMed ID: 35285503
[TBL] [Abstract] [Full Text] [Related]
19. GZ17-6.02 and axitinib interact to kill renal carcinoma cells.
Booth L; West C; Moore RP; Hoff DV; Dent P
Oncotarget; 2022; 13():281-290. PubMed ID: 35136485
[TBL] [Abstract] [Full Text] [Related]
20. Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section.
Nientiedt M; Waldbillig F; Stroop F; Nuhn P; Erben P; Popovic ZV; Weis CA; Michel MS; Kriegmair MC
Urol Int; 2022; 106(8):816-824. PubMed ID: 35124681
[TBL] [Abstract] [Full Text] [Related]
[Next]
